Senvest Management, LLC Bluebird Bio, Inc. Transaction History

Senvest Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $2.15 Million - $4.39 Million	-129,633 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $1.89 Million - $2.61 Million	-68,770 Reduced 34.66%	129,633 $5.61 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $2.23 Million - $2.83 Million	64,700 Added 48.39%	198,403 $10.7 Million
Q2 2020 Aug 13, 2020	BUY	$27.12 - $45.97 $3.63 Million - $6.15 Million	133,703 New	133,703 $8.16 Million

144

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $644M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Senvest Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Senvest Management, LLC with notifications on news.